Co-Diagnostics raises $3.0M in private placement of stock and warrants at $1.821/unit

Co-Diagnostics, Inc.

Gross proceeds of $3.0M from sale of 1.65M shares/pre-funded warrants and 3.29M common warrants.
Common warrants exercisable immediately at $1.571/share, expire in five years; pre-funded warrants at $0.0001.
Offering priced at-the-market under Nasdaq rules; expected to close May 21, 2026.
Maxim Group LLC acted as sole placement agent; net proceeds for general corporate purposes and working capital.
Company agreed to file a resale registration statement within 15 days to register the securities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.